Zujun Fang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
The mystery of abdominal snow-grip sensation: emphysematous cystitis complicated with bladder gangrene and rupture-case report and literature review.
Journal: Frontiers in medicine
Published: June 13, 2024
Can uric acid affect the immune microenvironment in bladder cancer? A single-center multi-omics study.
Journal: Molecular carcinogenesis
Published: September 21, 2023
Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 14, 2023
5-Aminolevulinic acid combined with ferrous iron ameliorates scrotal heat stress-induced spermatogenic damage by enhancing HO-1 expression.
Journal: Molecular biology reports
Published: January 31, 2023
Systematic evaluation of narrow-sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort.
Journal: Clinical genetics
Published: November 17, 2022
Extracellular vesicles from human urine-derived stem cells merged in hyaluronic acid ameliorate erectile dysfunction in type 2 diabetic rats by glans administration.
Journal: Andrology
Published: April 08, 2022
Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Frontiers in pharmacology
Published: December 22, 2021
A Germline Variant at 8q24 Contributes to the Serum p2PSA Level in a Chinese Prostate Biopsy Cohort.
A Germline Variant at 8q24 Contributes to the Serum p2PSA Level in a Chinese Prostate Biopsy Cohort.
Journal: Frontiers in oncology
Published: August 05, 2021
Genetic risk scores based on risk-associated single nucleotide polymorphisms can reveal inherited risk of bladder cancer in Chinese population.
Journal: Medicine
Published: May 09, 2020
Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.
Journal: Cancer medicine
Published: September 16, 2017
Results of a randomized, double-blind, active-controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladder.
Journal: BJU international
Published: April 19, 2016
Last Updated: 09/26/2026